Clinical Trial

Comparison of 3 RF Delivery Modes of the QDOT Catheter for Paroxymal Atrial Fibrillation (AF) Ablation

Study acronym: QDOT
Recruiting
View on ClinicalTrials.gov →
Summary
Pulmonary vein isolation is the main treatment of paroxysmal and persistent atrial fibrillation. The aim of our study is to prospectively compare the efficacy and safety of the 3 options of radiofrequency delivery with QDOT Micro™, with systematic use of catheter stabilization tools and tighter lesions
Trial Details
NCT Number NCT06647251
Lead Sponsor Institut Mutualiste Montsouris
Conditions Atrial Fibrillation
Enrollment 90 participants
Start Date 2024-10
Primary Completion 2027-10 (estimated)
Study Completion 2028-10 (estimated)
Updated on ClinicalTrials.gov 2024-10-17